US Stock MarketDetailed Quotes

ARS Pharmaceuticals (SPRY)

Watchlist
  • 8.630
  • +0.030+0.35%
Close May 12 16:00 ET
  • 8.700
  • +0.070+0.81%
Post 20:01 ET
856.96MMarket Cap-4.96P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ARS Pharmaceuticals (SPRY) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-1,361.19%-170.87M
-203.53%-43.49M
-225.20%-47.05M
-443.92%-39.59M
-507.18%-40.74M
122.86%13.55M
341.33%42M
-13.35%-14.47M
56.33%-7.28M
46.01%-6.71M
Net income from continuing operations
-2,241.76%-171.3M
-182.76%-41.32M
-167.41%-51.15M
-258.60%-44.88M
-229.77%-33.94M
114.71%8M
796.62%49.93M
-28.67%-19.13M
27.94%-12.52M
31.21%-10.29M
Depreciation and amortization
42.08%-4.16M
61.32%-586K
61.16%-701K
37.01%-1.19M
14.63%-1.68M
-5.90%-7.18M
11.66%-1.52M
-17.28%-1.81M
-8.89%-1.89M
-10.06%-1.97M
Other non cash items
--337K
--151K
----
----
----
----
----
----
----
----
Change In working capital
-1,005.80%-20M
30.11%-7.46M
-137.22%-1.07M
-127.99%-1.05M
-565.97%-10.42M
75.42%-1.81M
1.13%-10.68M
178.32%2.88M
1,021.79%3.76M
7.97%2.24M
-Change in receivables
-110.46%-17.21M
251.00%11.18M
-1,712.03%-14.01M
---13.25M
---1.13M
---8.18M
---7.4M
---773K
--0
--0
-Change in inventory
-269.82%-21.99M
-68.64%-9.72M
626.23%963K
---4.78M
---8.45M
---5.95M
---5.76M
---183K
--0
--0
-Change in prepaid assets
110.60%656K
103.92%284K
312.10%1.07M
488.09%4.1M
-653.17%-4.8M
-331.43%-6.19M
-278.44%-7.25M
-472.73%-504K
462.10%697K
94.83%867K
-Change in payables and accrued expense
15.04%18.88M
-218.27%-9.06M
152.68%10.96M
317.91%12.81M
210.12%4.17M
691.03%16.41M
186.30%7.66M
286.03%4.34M
1,268.75%3.07M
-71.74%1.34M
-Change in other current assets
----
----
----
----
--0
----
----
----
----
--30K
-Change in other working capital
-116.75%-350K
-106.80%-143K
-73.53%-59K
164.00%66K
-4,180.00%-214K
166.34%2.09M
70,200.00%2.1M
-1,033.33%-34K
292.31%25K
99.84%-5K
Cash from discontinued investing activities
Operating cash flow
-1,361.19%-170.87M
-203.53%-43.49M
-225.20%-47.05M
-443.92%-39.59M
-507.18%-40.74M
122.86%13.55M
341.33%42M
-13.35%-14.47M
56.33%-7.28M
46.01%-6.71M
Investing cash flow
Cash flow from continuing investing activities
153.50%56.77M
123.70%24.11M
-367.46%-44.98M
484.08%48.57M
441.41%29.06M
-21.70%-106.1M
-490.80%-101.76M
136.06%16.82M
-128.12%-12.65M
92.37%-8.51M
Net PPE purchase and sale
39.79%-339K
--0
-40.71%-197K
-34.21%-51K
-9.64%-91K
-221.71%-563K
-431.87%-302K
-225.58%-140K
-26.67%-38K
56.99%-83K
Net investment purchase and sale
166.27%64.97M
127.07%26.11M
-300.04%-38.92M
485.64%48.62M
445.85%29.16M
-12.68%-98.04M
-471.74%-96.46M
141.76%19.46M
-128.02%-12.61M
92.43%-8.43M
Net other investing changes
-4.80%-7.86M
60.00%-2M
----
----
----
---7.5M
---5M
----
----
----
Cash from discontinued investing activities
Investing cash flow
153.50%56.77M
123.70%24.11M
-367.46%-44.98M
484.08%48.57M
441.41%29.06M
-21.70%-106.1M
-490.80%-101.76M
136.06%16.82M
-128.12%-12.65M
92.37%-8.51M
Financing cash flow
Cash flow from continuing financing activities
44.47%104.6M
-98.41%1.13M
14,612.50%100.05M
394.86%2.7M
181.01%725K
949.41%72.4M
3,828.86%70.92M
-26.17%680K
-80.90%545K
-80.44%258K
Net issuance payments of debt
--96.26M
---732K
----
----
----
--0
--0
----
----
----
Proceeds from stock option exercised by employees
88.36%5.68M
16.11%1.78M
-29.56%479K
394.86%2.7M
181.01%725K
-56.28%3.02M
-15.07%1.53M
-26.17%680K
-80.90%545K
-80.44%258K
Net other financing activities
-96.17%2.66M
--83K
----
----
----
--69.38M
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
44.47%104.6M
-98.41%1.13M
14,612.50%100.05M
394.86%2.7M
181.01%725K
949.41%72.4M
3,828.86%70.92M
-26.17%680K
-80.90%545K
-80.44%258K
Net cash flow
Beginning cash position
-28.40%50.82M
50.18%59.56M
40.72%51.54M
-28.82%39.86M
-28.40%50.82M
-66.29%70.97M
-34.49%39.66M
-69.23%36.63M
-36.26%56.01M
-66.29%70.97M
Current changes in cash
52.86%-9.5M
-263.44%-18.24M
164.50%8.02M
160.25%11.68M
26.81%-10.95M
85.56%-20.15M
6.91%11.16M
105.18%3.03M
-162.21%-19.38M
87.80%-14.97M
End cash Position
-18.69%41.32M
-18.69%41.32M
50.18%59.56M
40.72%51.54M
-28.82%39.86M
-28.40%50.82M
-28.40%50.82M
-34.49%39.66M
-69.23%36.63M
-36.26%56.01M
Free cash flow
-1,418.48%-171.21M
-204.28%-43.49M
-223.43%-47.24M
-441.79%-39.64M
-501.10%-40.83M
121.85%12.99M
340.86%41.7M
-14.06%-14.61M
56.18%-7.32M
46.18%-6.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -1,361.19%-170.87M-203.53%-43.49M-225.20%-47.05M-443.92%-39.59M-507.18%-40.74M122.86%13.55M341.33%42M-13.35%-14.47M56.33%-7.28M46.01%-6.71M
Net income from continuing operations -2,241.76%-171.3M-182.76%-41.32M-167.41%-51.15M-258.60%-44.88M-229.77%-33.94M114.71%8M796.62%49.93M-28.67%-19.13M27.94%-12.52M31.21%-10.29M
Depreciation and amortization 42.08%-4.16M61.32%-586K61.16%-701K37.01%-1.19M14.63%-1.68M-5.90%-7.18M11.66%-1.52M-17.28%-1.81M-8.89%-1.89M-10.06%-1.97M
Other non cash items --337K--151K--------------------------------
Change In working capital -1,005.80%-20M30.11%-7.46M-137.22%-1.07M-127.99%-1.05M-565.97%-10.42M75.42%-1.81M1.13%-10.68M178.32%2.88M1,021.79%3.76M7.97%2.24M
-Change in receivables -110.46%-17.21M251.00%11.18M-1,712.03%-14.01M---13.25M---1.13M---8.18M---7.4M---773K--0--0
-Change in inventory -269.82%-21.99M-68.64%-9.72M626.23%963K---4.78M---8.45M---5.95M---5.76M---183K--0--0
-Change in prepaid assets 110.60%656K103.92%284K312.10%1.07M488.09%4.1M-653.17%-4.8M-331.43%-6.19M-278.44%-7.25M-472.73%-504K462.10%697K94.83%867K
-Change in payables and accrued expense 15.04%18.88M-218.27%-9.06M152.68%10.96M317.91%12.81M210.12%4.17M691.03%16.41M186.30%7.66M286.03%4.34M1,268.75%3.07M-71.74%1.34M
-Change in other current assets ------------------0------------------30K
-Change in other working capital -116.75%-350K-106.80%-143K-73.53%-59K164.00%66K-4,180.00%-214K166.34%2.09M70,200.00%2.1M-1,033.33%-34K292.31%25K99.84%-5K
Cash from discontinued investing activities
Operating cash flow -1,361.19%-170.87M-203.53%-43.49M-225.20%-47.05M-443.92%-39.59M-507.18%-40.74M122.86%13.55M341.33%42M-13.35%-14.47M56.33%-7.28M46.01%-6.71M
Investing cash flow
Cash flow from continuing investing activities 153.50%56.77M123.70%24.11M-367.46%-44.98M484.08%48.57M441.41%29.06M-21.70%-106.1M-490.80%-101.76M136.06%16.82M-128.12%-12.65M92.37%-8.51M
Net PPE purchase and sale 39.79%-339K--0-40.71%-197K-34.21%-51K-9.64%-91K-221.71%-563K-431.87%-302K-225.58%-140K-26.67%-38K56.99%-83K
Net investment purchase and sale 166.27%64.97M127.07%26.11M-300.04%-38.92M485.64%48.62M445.85%29.16M-12.68%-98.04M-471.74%-96.46M141.76%19.46M-128.02%-12.61M92.43%-8.43M
Net other investing changes -4.80%-7.86M60.00%-2M---------------7.5M---5M------------
Cash from discontinued investing activities
Investing cash flow 153.50%56.77M123.70%24.11M-367.46%-44.98M484.08%48.57M441.41%29.06M-21.70%-106.1M-490.80%-101.76M136.06%16.82M-128.12%-12.65M92.37%-8.51M
Financing cash flow
Cash flow from continuing financing activities 44.47%104.6M-98.41%1.13M14,612.50%100.05M394.86%2.7M181.01%725K949.41%72.4M3,828.86%70.92M-26.17%680K-80.90%545K-80.44%258K
Net issuance payments of debt --96.26M---732K--------------0--0------------
Proceeds from stock option exercised by employees 88.36%5.68M16.11%1.78M-29.56%479K394.86%2.7M181.01%725K-56.28%3.02M-15.07%1.53M-26.17%680K-80.90%545K-80.44%258K
Net other financing activities -96.17%2.66M--83K--------------69.38M----------------
Cash from discontinued financing activities
Financing cash flow 44.47%104.6M-98.41%1.13M14,612.50%100.05M394.86%2.7M181.01%725K949.41%72.4M3,828.86%70.92M-26.17%680K-80.90%545K-80.44%258K
Net cash flow
Beginning cash position -28.40%50.82M50.18%59.56M40.72%51.54M-28.82%39.86M-28.40%50.82M-66.29%70.97M-34.49%39.66M-69.23%36.63M-36.26%56.01M-66.29%70.97M
Current changes in cash 52.86%-9.5M-263.44%-18.24M164.50%8.02M160.25%11.68M26.81%-10.95M85.56%-20.15M6.91%11.16M105.18%3.03M-162.21%-19.38M87.80%-14.97M
End cash Position -18.69%41.32M-18.69%41.32M50.18%59.56M40.72%51.54M-28.82%39.86M-28.40%50.82M-28.40%50.82M-34.49%39.66M-69.23%36.63M-36.26%56.01M
Free cash flow -1,418.48%-171.21M-204.28%-43.49M-223.43%-47.24M-441.79%-39.64M-501.10%-40.83M121.85%12.99M340.86%41.7M-14.06%-14.61M56.18%-7.32M46.18%-6.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +24.74%
Sample Name
Sample Code
 +22.84%
Sample Name
Sample Code
 +19.74%
4
United States Oil Fund LP
USO
+16.51%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+14.47%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +14.63%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +6.10%
4
Li Auto
LI
+5.40%
5
Vipshop
VIPS
+3.19%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -